Prenetics

Prenetics Global Limited (NASDAQ: PRE) is a health sciences company incorporated in the Cayman Islands and headquartered in the USA and Hong Kong. Founded in 2014, Prenetics focuses on advancing consumer and clinical health through innovative solutions in genetic testing and early disease detection. Its consumer initiatives are led by IM8, a health and wellness brand, while its clinical division includes Insighta, a $200 million venture dedicated to multi-cancer early detection technologies. Additionally, Prenetics offers comprehensive DNA testing services through CircleDNA, utilizing next-generation sequencing technology to provide insights into health, wellness, and genetic predispositions. (prenetics.com)

In February 2025, Prenetics announced a partnership with Humanity Protocol, a decentralized identity verification company. This collaboration integrates Prenetics' CircleDNA service into Humanity Protocol's infrastructure, enabling the issuance of blockchain-based Proof of Personhood credentials. This initiative underscores Prenetics' commitment to merging genomics with blockchain technology to enhance secure identity verification. (nasdaq.com)

As of June 19, 2025, Prenetics' stock is trading at $9.26, reflecting investor confidence in its strategic initiatives and market position.

Recent Developments

• June 18, 2025: Prenetics reported holding 187.42 BTC, valued at $19,602,339 at that time. (nasdaq.com)

• February 11, 2025: Prenetics announced a partnership with Humanity Protocol to enhance blockchain-based identity verification. As part of this initiative, the company invested $1.5 million in digital assets, including Bitcoin, Solana, and H tokens. (nasdaq.com)

These developments highlight Prenetics' proactive approach in integrating blockchain technology and digital assets into its business model, positioning itself at the forefront of innovation in the health sciences sector.